updat analysi show pfizer vaccin 95 percent effect the verg skip main content clock menu morearrow yes the verg homepag follow the verg onlin follow the verg facebook follow the verg twitter rss feed stori the verg log sign log in sign up site search search search the verg main menu tech review scienc creator entertain video featur podcast newslett store more tech video amazon appl facebook googl microsoft samsung tesla ai car cybersecur mobil polici privaci scooter all tech review phone laptop headphon camera tablet smartwatch speaker drone accessori buy guid howto deal more verg review scienc video space nasa spacex health energi environ all scienc creator youtub instagram adob kickstart tumblr art club camera photographi what bag all creator entertain film tv game fortnit game throne book comic music all entertain video featur podcast newslett store file scienc health coronavirus updat analysi show pfizer vaccin 95 percent effect the compani get readi file fda author by nicol wetsman nov 18 2020 1105am est share stori share facebook share twitter share all share option share all share option updat analysi show pfizer vaccin 95 percent effect linkedin reddit pocket flipboard email photo sarah silbigergetti imag pfizer biontech said wednesday updat analysi phase 3 clinic trial covid19 vaccin show 95 percent effect they plan file author food drug administr within day in press releas compani said 170 case covid19 among particip trial of case 162 record peopl took placebo eight record peopl receiv vaccin ten case sever nine sever case occur placebo group that indic vaccin protect deadliest form diseas moderna releas data trial week similar find pfizer also said vaccin 94 percent effect peopl age 65 that remark yale immunologist akiko iwasaki told the new york time we know influenza vaccin difficult achiev protect age group vaccin said this age group high risk sever case covid19 protect critic goal the new data updat announc last week base earlier analys trial data found vaccin 90 percent effect now pfizer biontech said theyv collect two month followup safeti data fda ask see compani ask author no serious safeti concern came trial the common side effect fatigu headach pfizer biontech said plan ask fda emerg use author eua vaccin isnt full approv moderna plan ask eua well the agenc issu author public health emerg like one approv product avail specif diseas they happen quick slight lower bar approv most treatment covid19 first releas eua the fda cautious eua vaccin therapeut alison batemanhous bioethicist assist professor depart popul health nyu grossman school medicin told the verg theyr given healthi peopl sick peopl you alway greater burden someth healthi person versus tri interven behalf sick person batemanhous said in octob agenc rais bar amount data want compani provid ask eua the twomonth safeti followup part guidanc the fda ask vaccin advisori committe plan meet decemb 8th 9th 10th discuss covid19 vaccin cnbc report thatd import step author process state alreadi prepar receiv dose vaccin distribut theyr approv iowa health offici said expect get shipment pfizer biontech vaccin soon theyr readi start vaccin soon fda sign state plan start vaccin health care worker other highrisk group like peopl nurs home essenti worker peopl health condit like diabet would next line vaccin general popul could start earli april anthoni fauci director nation institut allergi infecti diseas told cnn in this stream coronavirus disrupt world updat pandem multidos covid19 vaccin test state track system updat analysi show pfizer vaccin 95 percent effect microsoft say hacker russia north korea attack covid19 vaccin maker view 571 stori next up in scienc verg deal the best cyber monday deal tech anoth big wave deal arriv leftov cant eat black friday deal still get you still shot get musthav tech discount more verg deal sign newslett processor a newslett comput email requir by sign agre privaci notic european user agre data transfer polici subscrib chorus term use privaci notic cooki polici do not sell my person info licens faq access platform status contact tip us communiti guidelin about ethic statement vox media vox media vox media logo advertis us job vox media 2020 vox media llc all right reserv share stori twitter facebook
